Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CurveBeam Connect: How Legislators Got On Board with Cone Beam CT

Belgian surgeons were beginning to utilize cone beam CT several years ago. Then, doctors like AZ Groeninge Kortrijk’s Dr. Frederik Vanrietvelde suddenly had to slow their use of the modality because of price concerns, with cone beam CT suddenly left off a crucial list made by legislators. Vanrietvelde and some colleagues lobbied to make…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from CurveBeam AI on MarketScale.

Share

Belgian surgeons were beginning to utilize cone beam CT several years ago.

Then, doctors like AZ Groeninge Kortrijk’s Dr. Frederik Vanrietvelde suddenly had to slow their use of the modality because of price concerns, with cone beam CT suddenly left off a crucial list made by legislators.

Vanrietvelde and some colleagues lobbied to make sure it was included, noting that it met the definition of a CT scan approved for reimbursement by the government and that its absence was simply a mistake.

“If you look very closely, you could tell cone beam CT also corresponds to these particular parameters they use, so it should have been on this list, anyway,” he said. “So, there was really no reason why it shouldn’t be on the list, and they really never argued that what we were asking was not correct. They simply said, ‘Sorry, we forgot it. We have to correct it.’”

Even still, the process took two years for hospitals to once again be able to bill cone beam CT in the same way they were billing a more traditional CT scan. With that being the case, the numbers of Belgian doctors utilizing the technology remain relatively small.

Still, Vanrietvelde is confident their numbers will grow now that the scans are more accessible, and he said the most important thing was to put himself into others’ shoes.

“It’s always a difficult balance you have to do as a legislator. I’m thinking as a radiologist, and the patient is thinking as a patient. A legislator has to think as a legislator and think about budget balance, so my main advice would be come together,” he said. “Let’s get all those people together with different mindsets and different perspectives before you decide how to reimburse something.”

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

CurveBeam AI

Part of this channel

CurveBeam AI

AI-powered 3D bone analysis for orthopedic surgical planning.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512